CLINICAL_TRIALS
trial_result
· 2021-07-26
Clinical Trial Update: Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion [Phase 1]
Summary
Phase 1 dermal safety study evaluating potential irritation of abametapir lotion for head lice has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dr. Reddy's Laboratories Limited | Conditions: Head Lice | Phase 1 | Status: COMPLETED | Results posted: 2021-07-26